Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17
Attention Deficit Disorder With HyperactivityThe purpose of this study is to determine the effects of SPD503 compared to placebo on tasks of sustained attention in children and adolescents aged 6-17 diagnosed with ADHD.
Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17
Attention Deficit Disorder With HyperactivityThe purpose of this study is to determine the efficacy of SPD503 compared to placebo in the treatment of children and adolescents aged 6-17 with ADHD.
12 Month Open Extension of TNS for ADHD.
Attention Deficit Hyperactivity Disorder (ADHD)Participants who exhibit sufficient ADHD symptom improvement in a prior study of active TNS will be invited to continue in a 12-month extension study, designed to collect additional data on long-term response and tolerability and to provide participants ongoing clinical benefit from treatment.
Four-week Open-trial Extension TNS for ADHD
Attention Deficit Hyperactivity Disorder (ADHD)The purpose of this study will be to offer children previously randomized to sham treatment in a 5-week double-blind sham controlled study of Trigeminal Nerve Stimulation for ADHD (NCT02155608) an opportunity to receive 4-weeks active TNS treatment.
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD
Attention-Deficit/Hyperactivity Disorder (ADHD)This study will evaluate the efficacy and safety of SPN-812 (Viloxazine extended-release capsules; 200-600 mg) in adults 18-65 years of age with Attention-Deficit/Hyperactivity Disorder (ADHD).
Effectiveness of Behavioral Preschool Teacher Training for Externalizing
Attention Deficit and Disruptive Behavior DisordersProblem Behavior1 moreA cluster randomized controlled pre-post effectiveness trial of behavioral preschool teacher training (BPTT) delivered in a practitioner assisted group format for children with externalizing behavior problems. Preschools were randomized to either intervention in 25 preschools or as 22 waiting list control preschools, where teachers in preschool classes with the target child or children were program receivers. Participants were 100 target children 3-5 years old together with 72 enrolled preschool teachers and 83 parents as informants of behavioral outcomes after a five months period of implementation (at six months). The intervention was part of the Swedish evidence-based parent and teacher training programs (Comet) for children and youth with elevated externalizing behavior, and here an adapted version was tried in preschool for the first time. Also investigated was eventual generalized effects to the children's homes and improved social competence as an intermediate mechanism for reduced problem behavior. Effects of implementation fidelity in addition to social acceptability and relevance, such as reliable change, was investigated as well.
Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate
Attention Deficit Hyperactivity DisorderThe purpose of the AR19.004 study is to assess the efficacy of AR19 compared to placebo using the Adult ADHD Investigator Symptom Rating Scale (AISRS)
Transcranial Magnetic Stimulation for Attention Deficit/Hyperactivity Disorder (ADHD)
Attention Deficit Disorder With Hyperactivity (ADHD)This study will test the effects of transcranial magnetic stimulation (TMS) on clinical measures of ADHD symptoms.
Real World Evidence of the Efficacy and Safety of FOQUEST
Attention Deficit-Hyperactivity DisorderThis study is a four-month, phase IV, open-label study of ADHD symptomatology and functional outcomes in pediatric (6 to 17 years old) and adult (≥18 years or older) patients with ADHD treated with FOQUEST or VYVANSE.
the Cogmed Program for Youths With ADHD
ADHDADHD - Combined TypeThe primary objective of this study was to examine the effects of the Cogmed training program on working memory among youths 7 to 13 years old, while controlling presence and presentation of ADHD-related comorbidity. A secondary objective was to examine the generalization of effects to ADHD symptoms, non-verbal reasoning, attentional and executive functions, motor impulsivity, reading comprehension, and mathematical reasoning. Participants were under pharmacological treatment for ADHD combined type and a comorbidity. They were randomized into an experimental group that received the Cogmed program and an active control group that received a low-intensity comparison version of the training. They were evaluated at three time points: six weeks prior to intervention onset (T1), immediately prior to onset(T2), and one week following intervention completion (T3).